Charles Henry - A Case for Affecting the Condition Known as: Morgellons: with SSKI (Super Saturated Potassium Iodide)

A case for affecting the condition known as Morgellons with SSKI, using the known protocol for treating sporotrichosis as a guide.
Published for Charles Henry by Morgellons Direct LLC
___________________________________________________________
Charles Henry, patient, layman

1. This is not a medical document and is only presented in this form for ease of understanding the material. The author is merely sharing non-professional experience in self treating an uncommon condition in the interest of making the insights available to interested parties.

___________________________________________________________

Abstract

The purpose of this paper is to share my own successful experiences in self-treating the condition that has come to be known as Morgellons, utilizing SSKI (saturated solution of potassium iodide) . While describing my own observations of the condition as it presented in myself. I will discuss the discrepancies in the concentration of KI as described in the known medical protocol for using SSKI in treating sporotrichosis. In comparison to my own experiences in attempting to follow that protocol . I will suggest that the condition is an as-yet unidentified human pathogen in the dimorphic fungus family.

This document should not be confused with, or as being, any sort of medical documentation, as it is written well outside of any professional circles and is merely the observations of a layman in the process of self-treatment after finding professional medical help unavailable.

___________________________________________________________

Introduction

The following is based in my own experience and observations in examining and self-treating the condition referred to as Morgellons between the years 2000 to 2017. During the time of this illness, the condition had reached chronic levels before I realized the parallels of the symptoms I was experiencing to the condition(s) known as sporotrichosis. I then successfully followed the protocol for using SSKI in treating sporotrichosis commonly found in medical literature.

___________________________________________________________

Case Report / Patient history

Caucasian male, born in 1963, raised in western Washington State, in a wooded environment until teen years. Relocated to central Oklahoma at age 16. The condition initially presented during a trip to western Washington at age 39. This subject has resided in central Oklahoma since that time and during the course of the illness and treatment.
My condition became noticeable around the year 2000 when pimple-like sores became present in the skin of my torso . I found no relief from treating with calamine lotion or other common home remedies. In the following few years, the condition had become primarily present on my ankles, shins, hands, and forearms . After first appearing as the small pimple-type sores , they became larg e round lesions with a raised edges that would eventually create a faux healing by covering with what appeared to be a callous. Excessive scratching of newly affected areas could cause large patches of epidermis to break free from the dermis and peel away, revealing what appeared to be white fungal growths in the pores of the dermis. I treated topically with an antifungal cream with noticeable improvement, but limited success. I visited a General Practitioner, and later , a Dermatologist who only performed cursory examinations of my symptoms, and then, only prescribed psychiatric drugs, which were of no use in addressing the condition. In 2006, I turned to the internet to search for fungal conditions that paralleled my symptoms and immediately became distracted from that area of study by the Morgellons phenomenon that was blossoming online. Finding parallels in symptoms and similar unhe lpful experience with doctors in that online community of sufferers, I joined them in hoping for answers from the CDC or the medical community. I broke contact with those communities in 2008 after the study performed by Kaiser Permanente produced no helpful results.
In the years leading up to 2015 , my health was greatly deteriorating as I experimented on myself in a race to find answers before potentially losing the fight to the ailment. I had tried every topical treatment conceivable, to limited affect. Eventually, I made the drastic decision to use a wart removal product to freeze every affected location in order to determine whether the condition was topical or systemic. The condition did not , and apparently could not , return to areas of skin that had been frozen, but did return in other areas. I took this as evidence of a systemic condition and proceeded to carefully experiment with various internal treatments, including a trip to Mexico for a full run of powerful , injectable antibiotics , ultimately to no avail. By Fall of 2015, I had resigned to succumbing to the condition and was preparing to lie down , to finish being consumed by it, in full knowledge that it was an unknown systemic condition. During these years , I had been writing on my private FaceBook page o f my illness and experiences and an adult-age niece contacted me. She had been reading th e information I was posting and, after research, found parallels in what I was describing and a fungal infection known as sporotrichosis. I leapt at the opportunity for hope and dug in quickly to study the information available online. I saw enough parallels in the symptoms to believe in a possible connection . Si nce a medically recognized treatment option was within my grasp in following the protocol for using a saturated solution of potassium iodide, (SSKI), I had nothing to lose in trying it, and sourced the materials immediately.

Important to note at this time : During the treatment, I learned that there is discrepancy in the SSKI protocol described in medical literature and in reality. (1) Medical literature apparently assumes a .50ml drop of SSKI contains .50mg of potassium iodide, (KI,) while the reality is that a .50ml drop of SSKI contains .70mg of KI. This discrepancy makes the higher dosage amounts described in medical literature of as much as 50 to 55 drops, three times per day, inaccurate and entirely too much. I was not aware of this at the time, but was determined to follow the protocol . F or as many as 10 weeks, I did use 50 drops, three times per day, to a very miserable effect as to how I felt, but that only culminated in the medical result of an increased heart rate during that use and a possible sensitivity to potassium iodide that faded over a few weeks. I remained dedicated to the protocol because the positive effects on my well being were almost immediate and in time, I learned of the discrepancy regarding the protocol. After 15 years of an untreated systemic fungal infection, my entire body was involved and even normal movement was restricted and painful. The fatigue was intense, and I had the feeling of a weight around my neck that forced me to hunch forward. While the effects of the SSKI were quickly noticed in the reduced activity/fungal growth of the lesions, the positive effect on the fatigue and related aching symptoms was nearly immediate. With these effects combined, I was convinced that I had stumbled onto the answer which drove me forward in consuming the massive amounts of KI described in the medical literature, despite the discomfort of doing so. I would later learn that there are described amounts of KI used for these purposes measured in grams. It is a simple matter of basic math to figure the number of .07g drops appropriate for treatment to achieve 2g to 3g per day, dependent on the patients tolerance, as is the recognized range for effective treatment. (2)

According to my own condition, and from discussions with other sufferers, the Morgellons condition initially presents as a variety of unusual complaints. These complaints range from numerous black specks emerging from the skin, to tiny white fibers that resemble cotton strands emerging from the skin, (sometimes with noticeable movement of the white fibers). In later stages, complaints include weeping lesions that contain unidentified yeast-like growths that are usually described as resembling worms or nematodes when forcibly removed from the lesion. Internal complaints include fatigue, joint pain, and gastric pain and discomfort. Diarrhea or constipation is common.